Is DGCRF or SBUX a better dividend investment in 2026?

DGCRF currently yields 2000000.00% with a 5% 5-year dividend growth rate. SBUX yields 2.75% with 5% growth. The better choice depends on your goal: DGCRF offers higher current income.

What is the dividend yield difference between DGCRF and SBUX?

DGCRF has a forward dividend yield of 2000000.00% ($2.00/share annually). SBUX yields 2.75% ($2.46/share annually). The yield gap is 1999997.25 percentage points.

Home › Compare › DGCRF vs SBUX

DGCRF vs SBUX: Dividend Comparison 2026

DGCRF yields 2000000.00% · SBUX yields 2.75%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 DGCRF wins by $4.879226400974806e+39M in total portfolio value

INVESTMENT

TIME HORIZON10 years

DGCRF

● Live price

2000000.00%

Share price

$0.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$4.879226400974806e+39M

Annual income

$4,878,746,539,330,970,000,000,000,000,000,000,000,000,000,000.00

Full DGCRF calculator →

SBUX

● Live price

2.75%

Share price

$89.59

Annual div

$2.46

5Y div CAGR

48.3%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$157.5K

Annual income

$65,840.13

Full SBUX calculator →

Portfolio growth — DGCRF vs SBUX

📍 DGCRF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	DGCRF	SBUX
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, DGCRF + SBUX cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

DGCRF pays

SBUX pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

DGCRF

Annual income on $10K today (after 15% tax)

$170,000,000.00/yr

After 10yr DRIP, annual income (after tax)

$4,146,934,558,431,324,500,000,000,000,000,000,000,000,000,000.00/yr

SBUX

Annual income on $10K today (after 15% tax)

$233.40/yr

After 10yr DRIP, annual income (after tax)

$55,964.11/yr

At 15% tax rate, DGCRF beats the other by $4,146,934,558,431,324,500,000,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of DGCRF + SBUX for your $10,000?

DGCRF: 50%SBUX: 50%

100% SBUX50/50100% DGCRF

Portfolio after 10yr

$2.439613200487403e+39M

Annual income

$2,439,373,269,665,485,000,000,000,000,000,000,000,000,000,000.00/yr

Blended yield

99.99%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on SBUX right now

DGCRF

No analyst data

Altman Z

-230.6

Piotroski

3/9

SBUX

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$104.00

+16.1% upside vs current

Range: $90.00 — $120.00

Altman Z

2.6

Piotroski

5/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

DGCRF buys

SBUX buys

No recent congressional trades found for DGCRF or SBUX in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricDGCRFSBUX

Forward yield	2000000.00% ✓	2.75%
Annual dividend / share	$2.00	$2.46 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	48.3% ✓
Portfolio after 10y	$4.879226400974806e+39M	$157.5K ✓
Annual income after 10y	$4,878,746,539,330,970,000,000,000,000,000,000,000,000,000,000.00 ✓	$65,840.13
Total dividends collected	$4.879195005460081e+39M	$127.5K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	Consumer Discretionary

Year-by-year: DGCRF vs SBUX ($10,000, DRIP)

Year	DGCRF Portfolio	DGCRF Income/yr	SBUX Portfolio	SBUX Income/yr	Gap
1← crossover	$200,010,700	$200,000,000.00	$11,107	$407.21	+$200.00M → DGCRF
2	$3,738,731,768,458	$3,738,517,757,009.35	$12,512	$626.87	+$3738731.76M → DGCRF
3	$65,315,062,866,930,490	$65,311,062,423,938,240.00	$14,366	$978.69	+$65315062866.92M → DGCRF
4	$1,066,400,830,062,625,000,000	$1,066,330,942,945,357,500,000.00	$16,929	$1,557.50	+$1066400830062625.00M → DGCRF
5	$16,272,182,796,453,826,000,000,000	$16,271,041,747,565,660,000,000,000.00	$20,658	$2,543.80	+$16272182796453826560.00M → DGCRF
6	$232,054,240,113,661,900,000,000,000,000	$232,036,828,878,069,680,000,000,000,000.00	$26,406	$4,302.22	+$2.3205424011366188e+23M → DGCRF
7	$3,092,799,066,104,688,500,000,000,000,000,000	$3,092,550,768,067,767,400,000,000,000,000,000.00	$35,877	$7,622.00	+$3.0927990661046884e+27M → DGCRF
8	$38,524,105,697,352,694,000,000,000,000,000,000,000	$38,520,796,402,351,967,000,000,000,000,000,000,000.00	$52,741	$14,352.64	+$3.8524105697352695e+31M → DGCRF
9	$448,468,826,014,798,700,000,000,000,000,000,000,000,000	$448,427,605,221,702,600,000,000,000,000,000,000,000,000.00	$85,676	$29,243.03	+$4.484688260147987e+35M → DGCRF
10	$4,879,226,400,974,806,000,000,000,000,000,000,000,000,000,000	$4,878,746,539,330,970,000,000,000,000,000,000,000,000,000,000.00	$157,513	$65,840.13	+$4.879226400974806e+39M → DGCRF

DGCRF vs SBUX: Complete Analysis 2026

DGCRF — Stock

Diagnocure, Inc., a life sciences company, develops and commercializes products relating to the diagnosis of cancer in Canada. It focuses on molecular diagnostic tests for the detection and management of cancer. The company offers PCA3 test for the diagnosis of prostate cancer; and Guanylyl Cyclase C (GCC) marker and Previstage GCC colorectal cancer staging test for colorectal cancer patients, as well as PCP, a multi marker prostate cancer test. It also provides gene expression and copy number variation analysis, mutation detection, SNP genotyping, and platform and laboratory environmental services. The company was formerly known as DiagnoCure Inc. 9342-8530 Québec Inc. was founded in 1994 and is headquartered in Quebec, Canada.

Full DGCRF Calculator →

SBUX — Consumer Discretionary

Starbucks Corporation, together with its subsidiaries, operates as a roaster, marketer, and retailer of specialty coffee worldwide. The company operates through three segments: North America, International, and Channel Development. Its stores offer coffee and tea beverages, roasted whole beans and ground coffees, single serve products, and ready-to-drink beverages; and various food products, such as pastries, breakfast sandwiches, and lunch items. The company also licenses its trademarks through licensed stores, and grocery and foodservice accounts. The company offers its products under the Starbucks, Teavana, Seattle's Best Coffee, Evolution Fresh, Ethos, Starbucks Reserve, and Princi brands. As of October 3, 2021, it operated 16,826 company-operated and licensed stores in North America; and 17,007 company-operated and licensed stores internationally. The company was founded in 1971 and is based in Seattle, Washington.

Full SBUX Calculator →

📬

Get this DGCRF vs SBUX comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

DGCRF vs SCHD DGCRF vs JEPI DGCRF vs O DGCRF vs KO DGCRF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.